Build status - In Progress

Implantation of the HeartMate 3 in Subjects with Heart Failure

Implantation of the HeartMate 3 in Subjects with Heart Failure
Recruiting
18 years - 99 years
All
Phase N/A
150 participants needed
1 Location

Brief description of study

This is a prospective, post-market, multi-center, non-blinded, single arm study of the HeartMate 3 Left Ventricular Assist System (LVAS). The objective of this study is to evaluate the implantation of the HM3.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Heart Failure,Heart Diseases,Cardiovascular Diseases
  • Age: 18 years - 99 years
  • Gender: All

Subject must be ≥ 18 years of age Subject is receiving the HM3 as their first LVAD

Updated on 04 Aug 2024. Study ID: 844962

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center